Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3187
Source ID: NCT00184665
Associated Drug: Insulin Detemir
Title: Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes|Diabetes Mellitus, Type 1
Interventions: DRUG: insulin detemir|DRUG: insulin NPH|DRUG: insulin aspart
Outcome Measures: Primary: HbA1c, after a two-year trial period | Secondary: Adverse events|Body weight|Antibodies|Body composition|Blood glucose|Hypoglycaemia
Sponsor/Collaborators: Sponsor: Novo Nordisk A/S
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 501
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2004-06
Completion Date: 2006-09
Results First Posted:
Last Update Posted: 2017-01-27
Locations: Novo Nordisk Investigational Site, Buenos Aires, Argentina|Novo Nordisk Investigational Site, Ciudad Autonoma de Bs As, C1405CWB, Argentina|Novo Nordisk Investigational Site, Ciudad Autónoma de BsAs, C1406FWY, Argentina|Novo Nordisk Investigational Site, Mar del Plata, B7602CBM, Argentina|Novo Nordisk Investigational Site, St Leonards, New South Wales, 2065, Australia|Novo Nordisk Investigational Site, Hobart, Tasmania, 7000, Australia|Novo Nordisk Investigational Site, Melbourne, Victoria, 3004, Australia|Novo Nordisk Investigational Site, Darlinghurst, 2010, Australia|Novo Nordisk Investigational Site, Melbourne, 3000, Australia|Novo Nordisk Investigational Site, Stones Corner, 4120, Australia|Novo Nordisk Investigational Site, Woodville, 5011, Australia|Novo Nordisk Investigational Site, Plovdiv, 4002, Bulgaria|Novo Nordisk Investigational Site, Sofia, 1431, Bulgaria|Novo Nordisk Investigational Site, Zagreb, 10 000, Croatia|Novo Nordisk Investigational Site, Vellore, Tamil Nadu, 632004, India|Novo Nordisk Investigational Site, Chennai, 600-013, India|Novo Nordisk Investigational Site, Hyderabad, 600034, India|Novo Nordisk Investigational Site, Mumbai, 400 0067, India|Novo Nordisk Investigational Site, Skopje, 1000, Macedonia, The Former Yugoslav Republic of|Novo Nordisk Investigational Site, Cheras, 56000, Malaysia|Novo Nordisk Investigational Site, Kota Bharu, Kelantan, 16150, Malaysia|Novo Nordisk Investigational Site, Bucharest, 020042, Romania|Novo Nordisk Investigational Site, Bucharest, 020475, Romania|Novo Nordisk Investigational Site, Johannesburg, Gauteng, 2193, South Africa|Novo Nordisk Investigational Site, Johannesburg, Gauteng, 27 11, South Africa|Novo Nordisk Investigational Site, Cape Town, Western Cape, 27 21, South Africa|Novo Nordisk Investigational Site, Bloemfontein, 27 51, South Africa|Novo Nordisk Investigational Site, Bornova-IZMIR, 35100, Turkey|Novo Nordisk Investigational Site, Istanbul, 34390, Turkey
URL: https://clinicaltrials.gov/show/NCT00184665

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress